Alithya Reports Q3 Net Earnings Amidst Significant Goodwill Impairment and Ongoing Internal Control Weakness
ALYAF sits 23% above its 52-week low of $0.95 on light trading volume (0.3× avg).
Summary
Alithya Group reported positive net earnings for Q3 2025, but a substantial goodwill and intangible asset impairment of $38.0 million for the nine-month period led to a significant year-to-date net loss. The company also disclosed an ongoing material weakness in its internal controls over financial reporting.
Key Events · Earnings and Guidance · ALYAF
-
Significant Goodwill and Intangible Impairment
The company recognized a $38.0 million impairment loss on goodwill and intangibles for the nine months ended December 31, 2025, primarily affecting its Canada and Industry Solutions cash-generating units due to unachieved profitability targets.
-
Ongoing Material Weakness in Internal Controls
Management identified an ongoing material weakness in internal control over financial reporting related to revenue processes for fixed-fee and time and material arrangements, a deficiency first reported in March 2025.
-
Mixed Revenue Performance
Q3 2025 revenues decreased slightly by 0.5% to $115.2 million, while year-to-date revenues increased by 4.4% to $363.6 million, driven by U.S. growth (including the eVerge acquisition) but offset by a decline in Canada.
-
Year-to-Date Net Loss Worsens
Despite Q3 2025 net earnings of $0.7 million, the significant impairment led to a year-to-date net loss of $30.1 million, a substantial increase from the $6.7 million loss in the prior year period.
Analysis · ALYAF · Technology
Alithya Group's latest 6-K filing reveals a mixed financial picture, with Q3 2025 net earnings of $0.7 million, a notable improvement from a loss in the prior year. However, the nine-month period was severely impacted by a $38.0 million impairment of goodwill and intangible assets, primarily in its Canada and Industry Solutions segments, indicating underperformance in these areas. This impairment, representing a substantial portion of the company's market capitalization, resulted in a significant year-to-date net loss of $30.1 million. Furthermore, the company continues to report a material weakness in its internal controls over financial reporting related to revenue processes, a critical governance concern that has been ongoing since March 2025. While adjusted EBITDA and operating cash flow showed some resilience, particularly year-to-date, the declining backlog and flat Q3 revenues, coupled with the large impairment and control issues, present a challenging outlook. The eVerge acquisition contributed to U.S. revenue growth, but overall new business momentum appears to be slowing.
How filings like this one have moved
In the 30 days to Oct 4, 2026, 36.7% of the 1015 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.63%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ALYAF was trading at $1.17 on OTC in the Technology sector, with a market capitalization of approximately $116.5M. The 52-week trading range was $0.95 to $1.97. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.